Literature DB >> 20486151

Exploring the 'RPRL' motif of apelin-13 through molecular simulation and biological evaluation of cyclic peptide analogues.

N J Maximilian Macaluso1, Robert C Glen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20486151     DOI： 10.1002/cmdc.201000061

Source DB:  PubMed          Journal:  ChemMedChem        ISSN： 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  11 in total

Review 1.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

Review 2.  Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery.

Authors:  Sanju Narayanan; Danni L Harris; Rangan Maitra; Scott P Runyon
Journal:  J Med Chem       Date:  2015-07-10       Impact factor: 7.446

Review 3.  The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR.

Authors:  Nigel A Chapman; Denis J Dupré; Jan K Rainey
Journal:  Biochem Cell Biol       Date:  2014-08-20       Impact factor: 3.626

Review 4.  Apelinergic System Structure and Function.

Authors:  Kyungsoo Shin; Calem Kenward; Jan K Rainey
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

Review 5.  Elucidating Solution Structures of Cyclic Peptides Using Molecular Dynamics Simulations.

Authors:  Jovan Damjanovic; Jiayuan Miao; He Huang; Yu-Shan Lin
Journal:  Chem Rev       Date:  2021-01-11       Impact factor: 60.622

Review 6.  Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system.

Authors:  Peiran Yang; Janet J Maguire; Anthony P Davenport
Journal:  Trends Pharmacol Sci       Date:  2015-07-01       Impact factor: 14.819

7.  Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension.

Authors:  Peiran Yang; Cai Read; Rhoda E Kuc; Guido Buonincontri; Mark Southwood; Rubben Torella; Paul D Upton; Alexi Crosby; Stephen J Sawiak; T Adrian Carpenter; Robert C Glen; Nicholas W Morrell; Janet J Maguire; Anthony P Davenport
Journal:  Circulation       Date:  2017-01-30       Impact factor: 29.690

8.  [Pyr1]Apelin-13(1-12) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr1]Apelin-13.

Authors:  Peiran Yang; Rhoda E Kuc; Aimée L Brame; Alex Dyson; Mervyn Singer; Robert C Glen; Joseph Cheriyan; Ian B Wilkinson; Anthony P Davenport; Janet J Maguire
Journal:  Front Neurosci       Date:  2017-02-28       Impact factor: 4.677

9.  Apelin conformational and binding equilibria upon micelle interaction primarily depend on membrane-mimetic headgroup.

Authors:  Kyungsoo Shin; Muzaddid Sarker; Shuya K Huang; Jan K Rainey
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

Review 10.  International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand.

Authors:  Cai Read; Duuamene Nyimanu; Thomas L Williams; David J Huggins; Petra Sulentic; Robyn G C Macrae; Peiran Yang; Robert C Glen; Janet J Maguire; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.